Analyst Ratings For NYSE:EVH – Evolent Health (NYSE:EVH)
Today, KeyCorp raised its price target on NYSE:EVH – Evolent Health (NYSE:EVH) to per share.
Some recent analyst ratings include
- 1/4/2018-Citigroup initiated coverage with a Buy rating.
- 12/3/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- On 5/22/2018 Jonathan Weinberg, General Counsel, sold 15,000 with an average share price of $20.02 per share and the total transaction amounting to $300,300.00.
- On 5/21/2018 Seth Blackley, President, sold 16,666 with an average share price of $19.39 per share and the total transaction amounting to $323,153.74.
- On 5/10/2018 Seth Blackley, President, sold 64,398 with an average share price of $17.63 per share and the total transaction amounting to $1,135,336.74.
- On 5/8/2018 Seth Blackley, President, sold 85,596 with an average share price of $17.08 per share and the total transaction amounting to $1,461,979.68.
- On 3/1/2018 Unitedhealth Group Inc, Director, sold 3,040,000 with an average share price of $13.70 per share and the total transaction amounting to $41,648,000.00.
- On 8/3/2017 Frank J. Williams, CEO, sold 16,300 with an average share price of $23.73 per share and the total transaction amounting to $386,799.00.
- On 8/1/2017 Steve Wigginton, CEO, sold 6,000 with an average share price of $24.64 per share and the total transaction amounting to $147,840.00.
Recent Trading Activity for NYSE:EVH – Evolent Health (NYSE:EVH)
Shares of NYSE:EVH – Evolent Health closed the previous trading session at 20.78 up +0.62 3.10% with 20.799999237060547 shares trading hands.